Type 2 responses determine skin rash during recombinant interleukin-2 therapy.

Saved in:
Bibliographic Details
Title: Type 2 responses determine skin rash during recombinant interleukin-2 therapy.
Authors: Sommer, Charline1 (AUTHOR), Neuhaus, Vanessa1 (AUTHOR), Gogesch, Patricia2 (AUTHOR), Flandre, Thierry3 (AUTHOR), Dehmel, Susann1 (AUTHOR), Sewald, Katherina1 (AUTHOR) Katherina.Sewald@item.fraunhofer.de
Source: Journal of Immunotoxicology. 2024 Suppl 1, Vol. 21, pS48-S59. 12p.
Database: Environment Complete
Full text is not displayed to guests.
Description
ISSN:1547691X
DOI:10.1080/1547691X.2024.2343359